The Application of Lifestyle Enhancing Validated Integrative Therapies for Everyday Pain in Cirrhosis
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT07792850
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cirrhoses, Liver
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- High-touch self-management program — BEHAVIORALTailored digital self-management program, individualized pain coaching, and a structured walking or meditation curriculum selected through Active Choice as the primary behavioral focus for 48 weeks. On-demand coaching for low-pain self-efficacy and optional group coaching sessions.
- Low-touch self-management program — BEHAVIORALAccess to the self-guided digital self-management platform with automated educational content and behavioral nudges for 48 weeks.
Study Details
The goal of this clinical trial is to test a low-touch vs high-touch drug-free pain self-management program that may help lower pain and improve quality of life for adults with cirrhosis and pain. Participants are assigned by chance to one of two study groups. The groups receive different levels of support. The main questions it aims to answer are: * Do the programs help lower pain? * Do the programs improve quality of life? * Is one program more effective than the other? Researchers will compare a low-touch self management program to a high-touch self-management program to see if the programs help manage pain. Participants in the low-touch arm will: * Learn new ways to manage pain without medication * Receive access to the self-guided digital self-management platform * Receive general behavioral text message nudges * Receive a free Fitbit to keep Participants in the high-touch arm will: * Learn new ways to manage pain without medication * Receive tailored access to the self-guided digital self-management platform * Received individualized pain coaching and optional group coaching sessions * Participate in a structured walking or meditation curriculum * Receive a free Fitbit to keep
Key Dates
- First listed
- Aug 28, 2026
- Start date
- Jan 1, 2027
- Status verified
- Aug 2026
- Primary completion
- Mar 1, 2030
- Completion
- Jun 1, 2030
Study Design
- Enrollment
- 625 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: High-TouchParticipants receive tailored digital self-management program, individualized pain coaching, and a structured walking or meditation curriculum selected through Active Choice as the primary behavioral focus for 48 weeks. The high-touch arm also includes on-demand coaching for low-pain self-efficacy and optional group coaching sessions.
- Experimental: Low-TouchParticipants receive access to the self-guided digital self-management platform with automated educational content and behavioral nudges for 48 weeks.
Primary Outcome Measure
Pain Interference [ Time Frame: 48 weeks ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94143 | Rayshawnda Davis, MS Jessica Rubin, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| University of Miami | Miami | Florida | 33136 | David Goldberg, MD (PRINCIPAL_INVESTIGATOR) |
| John Hopkins University | Baltimore | Maryland | 21205 | Alexandra Strauss, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan | Ann Arbor | Michigan | 48109 | Elliot Tapper, MD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic | Rochester | Minnesota | 55905 | Douglas Simonetto, MD (PRINCIPAL_INVESTIGATOR) |
| Columbia University | New York | New York | 10032 | Elizabeth Verna, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Marina Serper, MD, MS (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University | Nashville | Tennessee | 37232 | Ashley Spann, MD, MS (PRINCIPAL_INVESTIGATOR) |